| 000 | 01235 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516091513.0 | ||
| 264 | 0 | _c20120906 | |
| 008 | 201209s 0 0 eng d | ||
| 022 | _a1592-8721 | ||
| 024 | 7 |
_a10.3324/haematol.2011.061630 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLauseker, Michael | |
| 245 | 0 | 0 |
_aComment on "Second-generation tyrosine kinase inhibitors improve the survival of patients with chronic myeloid leukemia in whom imatinib therapy has failed" Haematologica 2011;96(12):1779-82. _h[electronic resource] |
| 260 |
_bHaematologica _cMay 2012 |
||
| 300 |
_ae14-5 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPiperazines _xadministration & dosage |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aPyrimidines _xadministration & dosage |
| 700 | 1 | _aPfirrmann, Markus | |
| 700 | 1 | _aHoffmann, Verena S | |
| 700 | 1 | _aHasford, Joerg | |
| 773 | 0 |
_tHaematologica _gvol. 97 _gno. 5 _gp. e14-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3324/haematol.2011.061630 _zAvailable from publisher's website |
| 999 |
_c21753080 _d21753080 |
||